Advances in Movement Disorders: The NYC Movement Disorder CME SymposiumEvent Date
April 7, 2013
7:30AM - 5:00PM
Icahn School of Medicine
1425 Madison Avenue
The Mount Sinai Medical Center
The Goldwurm Auditorium
New York, NY
Register for this course
This conference will provide a comprehensive review of current practices and emerging therapies movement disorders, including Parkinson disease, chorea, dystonia, and deep brain stimulation. This program will feature both didactic sessions as well as video case presentations, and has been designed to be highly interactive with ample opportunity for questions and answers. There will be a panel discussion of video case presentations, during which internationally renowned leaders of the field will present their diagnostic approach to unusual and challenging movement disorder cases. Specifically, the educational objectives are to increase competence and improve clinician practice in Parkinson disease, dystonia, Tourette syndrome, Huntington disease, chorea, gait disorders, the paroxysmal dyskinesias, the use of botulinum toxin therapy, and deep brain stimulation. The program will offer the provider a compendium of information that will better enable the clinician to care for movement disorder patients in 2013.
At the conclusion of this activity, participants will be able to:
- Accurately characterize abnormal movement phenomenology based on neurological exam, including recognition of chorea, myoclonus, tics, dystonia, bradykinesia, and various types of tremor (postural, kinetic, resting, rubral)
- Propose treatment options for a patient with Parkinson’s disease, as well as counsel a patient with Parkinson disease on latest research regarding pipeline pharmacotherapy, neuroprotection, and gene therapy.
- Formulate the most up-to-date diagnostic workup and treatment plan for the patient with primary and secondary dystonia
- Be able to recognize and diagnose the paroxysmal dyskinesias, and then create an appropriate treatment plan for these patients
- Create an initial injection plan for cervical dystonia, limb dystonia, blepharospasm, and hemifacial spasm using botulinum toxin, and describe the use and differences between the various types of toxins.
- Generate a differential diagnosis for the patient with chorea, given the clinical presentation and history, and order diagnostic workup including genetic testing, imaging, and other labs. Create a prioritized treatment plan for the patient with chorea, and explain risks and benefits of each therapy to the patient
- Evaluate the patient with gait disorder, and plan appropriate further workup and treatment plan, including imaging, lumbar drain, gait testing, or therapy for parkinsonism as indicated.
- Determine the appropriate candidate for deep brain stimulation for Parkinson disease, dystonia, Tourette syndrome and essential tremor, and counsel them appropriately of risks and benefits of the procedure
Who should attend?
Neurologists, internists, physician assistants, nurse practitioners, neurologists-in-training, nurses, and other allied health professionals involved in the care of patients with movement disorders.
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Verification of Attendance
Verification of attendance will be provided to all professionals.
The Icahn School of Medicine at Mount Sinai is in full compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations please contact the Page and William Black Post-Graduate School of Medicine at 212-731-7950.
It is the policy of MSSM to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.
$75 Practicing Physicians
$50 Nurse practitioners, physician assistants
Free: Resident, Fellows